6-MAPB
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
1-(benzofuran-6-yl)-N-methylpropan-2-amine
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1354631-79-0 |
ChemSpider | 32078890 |
Chemical data | |
Formula | C12H15NO |
Molecular mass | 189.25 |
|
|
|
6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives.[citation needed] 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.[1]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Articles with unsourced statements from October 2013
- Methamphetamines
- Benzofurans
- Designer drugs